Publications by authors named "Timothy Grese"

Claim this Profile
S
SUV39H2 is a vulnerability in glioblastoma stem cells enhanced by co-targeting SUV39H1.
Bihui Cao, Qiqi Xie, Chunying Li, Jensen Mast, Bokai Wang, Timothy A Grese

Epigenomics· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open Innovation Drug Discovery (OIDD): a potential path to novel therapeutic chemical space.
Maria Alvim-Gaston, Timothy Grese, Abdelaziz Mahoui, Alan D Palkowitz, Marta Pineiro-Nunez

Curr Top Med Chem· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(S)-N-{3-[1-cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of the mineralocorticoid receptor.
Michael G Bell, Douglas L Gernert, Timothy A Grese, Matthew D Belvo, Peter S Borromeo

J Med Chem· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potential.
Rieko Tanaka, Almudena Rubio, Nancy K Harn, Douglas Gernert, Timothy A Grese

Bioorg Med Chem· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetes.
Mark D Leibowitz, Robert J Ardecky, Marcus F Boehm, Carol L Broderick, Mark A Carfagna, Timothy A Grese

Endocrinology· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3,3-Bisaryloxindoles as mineralocorticoid receptor antagonists.
David A Neel, Matthew L Brown, Peter A Lander, Timothy A Grese, Jean M Defauw

Bioorg Med Chem Lett· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and structure-activity relationship of novel RXR-selective modulators.
Pierre-Yves Michellys, Jennifer D'Arrigo, Timothy A Grese, Donald S Karanewsky, Mark D Leibowitz

Bioorg Med Chem Lett· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of novel RXR-selective modulators with improved pharmacological profile.
Pierre-Yves Michellys, Marcus F Boehm, Jyun-Hung Chen, Timothy A Grese, Donald S Karanewsky

Bioorg Med Chem Lett· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and structure-activity relationship studies of novel 6,7-locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic acids.
Pierre-Yves Michellys, Robert J Ardecky, Jyun-Hung Chen, Jennifer D'Arrigo, Timothy A Grese

J Med Chem· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A chemical switch regulates fibrate specificity for peroxisome proliferator-activated receptor alpha (PPARalpha ) versus liver X receptor.
Jeffrey Thomas, Kelli S Bramlett, Chahrzad Montrose, Patricia Foxworthy, Patrick I Eacho, Timothy Grese

J Biol Chem· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective RXR modulators for the treatment of type II diabetes.
Margaret M Faul, Timothy A Grese

Curr Opin Drug Discov Devel· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention and treatment of experimental breast cancer with the combination of a new selective estrogen receptor modulator, arzoxifene, and a new rexinoid, LG 100268.
Nanjoo Suh, William W Lamph, Andrew L Glasebrook, Timothy A Grese, Alan D Palkowitz

Clin Cancer Res· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis